Professor, Department of Medical Nutrition, AgeTech-Service Convergence Major, Kyung Hee University, Yongin, Korea
© 2026 The Korean Society of Community Nutrition
This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
CONFLICT OF INTEREST
There are no financial or other issues that might lead to conflict of interest.
FUNDING
This research was supported by a grant from BK21 program “AgeTech- Service Convergence Major” through the National Research Foundation, funded by the Ministry of Education of Korea (Grant No. 5120200313836).
ACKNOWLEDGEMENTS
This study was based on a presentation delivered at the 2025 Fall Conference of the Korean Society of Community Nutrition.
DATA AVAILABILITY
This narrative review is based on previously published literature and does not contain original data.
Data from Shen et al. (Nat Aging 2024; 4(11): 1619-1634) [7].
KNHANES, Korean national health and nutrition examination survey; KDRI, Korean Dietary Reference Intake; EER, estimated energy requirement; RNI, recommended nutrient intake; EAR, estimated average requirement; AMDR, acceptable macronutrient distribution range; CDRR, chronic disease risk reduction intake; AI, adequate intake.
KNHANES, Korean national health and nutrition examination survey; KDRI, Korean Dietary Reference Intake; EER, estimated energy requirement; RNI, recommended nutrient intake; EAR, estimated average requirement; AMDR, acceptable macronutrient distribution range; CDRR, chronic disease risk reduction intake; AI, adequate intake.
| Biological aging crest | Approximate chronological age | Primary molecular & metabolic dysregulation | Clinical implications & associated risks |
|---|---|---|---|
| Crest 1 (early midlife transition) | 44 years | Lipid metabolism | Hyperlipidemia |
| Alcohol metabolism | Early atherosclerosis | ||
| Structural proteins in the skin and muscle | Metabolic syndrome | ||
| Cardiovascular disease pathways | Decline in muscle elasticity | ||
| Skin aging | |||
| Crest 2 (late midlife transition) | 60 years | Immune regulation | Immunosenescence |
| Carbohydrate metabolism | Type 2 diabetes onset | ||
| Oxidative phosphorylation | Profound loss of bone mineral density (osteoporosis) | ||
| Kidney function pathways | Accelerated sarcopenia |
| Nutrient | Age (year) | DRI | Mean intake (based on KNHANES 2013–2022) | Below the KDRI (%) |
|---|---|---|---|---|
| Energy (kcal/d) | 30–49 | EER: 2,500 | ~2,500 | - |
| 50–64 | EER: 2,200 | ~2,100–2,200 | - | |
| Protein (g/d) | 30–49 | RNI: 65 | 88.8 | 13.8 |
| EAR: 50 | ||||
| 50–64 | RNI: 60 | 80.6 | 21.1 | |
| EAR: 50 | ||||
| Fat (%/E) | 30–49 | AMDR: 15–30 | 20.7 | - |
| 50–64 | 16.7 | - | ||
| Saturated fatty acid (%/E) | 19–64 | CDRR: < 7% | Generally < 7% | - |
| Sugars (g/d) | 30–49 | Goal: < 20% of total energy | 63.3 | - |
| 50–64 | 60.8 | - | ||
| Calcium (mg/d) | 30–49 | RNI: 800 | 495.7 (median) | 71.4 |
| EAR: 650 | ||||
| 50–64 | RNI: 750 | 517.0 (median) | 64.6 | |
| EAR: 600 | ||||
| Vitamin D (μg/d) | 30–49 | AI: 10 | 3.5 | 92.6 |
| 50–64 | 4.0 | 92.1 | ||
| Vitamin A (μg RAE/d) | 30–49 | RNI: 800 | 410.6 | 78.8 |
| EAR: 560 | ||||
| 50–64 | RNI: 750 | 458.8 | 74.4 | |
| EAR: 530 | ||||
| Riboflavin (mg/d) | 30–49 | RNI: 1.5 | 1.91 | 29.0 |
| 50–64 | EAR: 1.3 | 1.75 | 34.1% | |
| Sodium (mg/d) | 30–49 | AI: 1,500 | 4,026.0 | Above CDRR: 83.4 |
| CDRR: 2,300 | Below AI: 5.0 | |||
| 50–64 | 3,942.2 | Above CDRR: 79.4 | ||
| Below AI: 5.3 |
| Nutrient | Age (year) | DRI | Mean intake (based on KNHANES 2013–2022) | Below the KDRI (%) |
|---|---|---|---|---|
| Energy (kcal/d) | 30–49 | EER: 1,900 | ~1,800–1,900 | - |
| 50–64 | EER: 1,700 | ~1,500–1,600 | - | |
| Protein (g/d) | 30–49 | RNI: 50 | 59.5 | 24.2 |
| EAR: 40 | ||||
| 50–64 | RNI: 60 | 59.3 | 22.6 | |
| EAR: 50 | ||||
| Fat (%/E) | 30–49 | AMDR: 15–30 | 21.1 | - |
| 50–64 | 17.5 | - | ||
| Saturated fatty acid (%/E) | 19–64 | CDRR: < 7% | Generally < 7% | - |
| Sugars (g/d) | 30–49 | Goal: < 20% of total energy | 50.8 | - |
| 50–64 | 61.5 | - | ||
| Calcium (mg/d) | 30–49 | RNI: 700 | 397.1 (median) | 74.0 |
| 50–64 | EAR: 580 | 437.1 (median) | 72.8 | |
| Vitamin D (μg/d) | 30–49 | AI: 10 | 2.6 | 95.6 |
| 50–64 | 3.1 | 95.5 | ||
| Vitamin A (μg RAE/d) | 30–49 | RNI: 650 | 350.2 | 76.2 |
| EAR: 450 | ||||
| 50–64 | RNI: 600 | 379.6 | 70.7 | |
| EAR: 430 | ||||
| Riboflavin (mg/d) | 30–49 | RNI: 1.2 | 1.41 | 31.0 |
| 50–64 | EAR: 1.0 | 1.40 | 29.1 | |
| Sodium (mg/d) | 30–49 | AI: 1,500 | 2722.6 | Above CDRR: 55.4 |
| CDRR: 2,300 | Below AI: 17.5 | |||
| 50–64 | 2769.2 | Above CDRR: 55.6 | ||
| Below AI: 17.5 |
| Target nutrient | Recommended intake dose for muscle preservation | Physiological role in middle-aged adults |
|---|---|---|
| Total dietary protein | 1.2–1.5 g/kg/day (or 25–30 g/meal) | Overcomes anabolic resistance and provides primary building blocks for muscle protein synthesis |
| Leucine (branched-chain amino acids) | 2.5–3.0 g/meal | Direct activator of the mTORC1 signaling pathway, initiating muscle anabolism |
| Vitamin D | 800–1,000 IU/day | Upregulates intramuscular vitamin D receptors and enhances fast-twitch muscle fiber function |
| Magnesium | 300 mg/day (men), 270 mg/day (women) | Co-factor in ATP synthesis and insulin signaling; mitigates age-related muscle mass loss |
| Vitamin C/E | 45–90 mg/day (vitamin C), 400 IU/day (vitamin E) | Decreases reactive oxygen species that exacerbate age-related muscle catabolism |
| Dietary component | MIND diet recommendation | Neuroprotective mechanism |
|---|---|---|
| Green leafy vegetables | ≥ 6 servings/week | Rich in folate, lutein, and vitamin K; suppresses neuroinflammation and maintains synaptic plasticity |
| Berries | ≥ 2 servings/week | Contains anthocyanins that promote neural signal transmission in the cerebral cortex and defend against oxidative stress |
| Extra virgin olive oil | Primary cooking fat | Oleocanthal activates the clearance of amyloid-beta (Aβ) plaques, which induce Alzheimer’s |
| Nuts & fish | Nuts ≥ 5 servings/week | Omega-3 (EPA, DHA) unsaturated fatty acids preserve brain cell membrane fluidity and protect microvessels |
| Fish ≥ 1 serving/week | ||
| Red meat & fast food | Red meat < 4 servings/week | Blocks generation of saturated fats and advanced glycation end-products, preventing damage to blood-brain barrier permeability |
| Fried food < 1 serving/week |
Data from Shen
KNHANES, Korean national health and nutrition examination survey; KDRI, Korean Dietary Reference Intake; EER, estimated energy requirement; RNI, recommended nutrient intake; EAR, estimated average requirement; AMDR, acceptable macronutrient distribution range; CDRR, chronic disease risk reduction intake; AI, adequate intake.
KNHANES, Korean national health and nutrition examination survey; KDRI, Korean Dietary Reference Intake; EER, estimated energy requirement; RNI, recommended nutrient intake; EAR, estimated average requirement; AMDR, acceptable macronutrient distribution range; CDRR, chronic disease risk reduction intake; AI, adequate intake.
Data from Kamei Data from Guasch-Ferré Data from Nasimi
